BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2052572)

  • 1. The TPR-MET oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions.
    Soman NR; Correa P; Ruiz BA; Wogan GN
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4892-6. PubMed ID: 2052572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TPR-MET oncogenic rearrangement: detection by polymerase chain reaction amplification of the transcript and expression in human tumor cell lines.
    Soman NR; Wogan GN; Rhim JS
    Proc Natl Acad Sci U S A; 1990 Jan; 87(2):738-42. PubMed ID: 2300559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of rearranged Tpr-met mRNA expression in human gastric cancer cell lines and gastric mucosa and carcinoma.
    Osaki M; Miyata H; Hayashi A; Gomyo Y; Tatebe S; Ito H
    Anticancer Res; 1996; 16(5A):2881-4. PubMed ID: 8917402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of tpr-met and expression of c-met in human gastric mucosa and carcinoma.
    Heideman DA; Snijders PJ; Bloemena E; Meijer CJ; Offerhaus GJ; Meuwissen SG; Gerritsen WR; Craanen ME
    J Pathol; 2001 Aug; 194(4):428-35. PubMed ID: 11523050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of TPR-MET rearrangement in patients with gastric carcinoma and in first-degree relatives.
    Yu J; Miehlke S; Ebert MP; Hoffmann J; Breidert M; Alpen B; Starzynska T; Stolte Prof M; Malfertheiner P; Bayerdörffer E
    Cancer; 2000 Apr; 88(8):1801-6. PubMed ID: 10760755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multiple gene alterations involved in the processor of human gastric carcinogenesis].
    Lu Y; Li Z; Sun M
    Zhonghua Yi Xue Za Zhi; 1995 Nov; 75(11):679-82, 710-1. PubMed ID: 8697090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene alterations in intestinal metaplasia and gastric cancer.
    Tahara E; Kuniyasu H; Yasui W; Yokozaki H
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S97-102. PubMed ID: 7735945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of ras gene mutation in gastric cancer and precancerous lesions.
    Hao Y; Zhang J; Lu Y; Yi C; Qian W; Cui J
    J Tongji Med Univ; 1998; 18(3):141-4. PubMed ID: 10806811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of ras gene mutation in various stages of gastric cancer by PCR/RFLP SSCP and DNA sequencing].
    Hao Y; Zhang J; Lu Y
    Zhonghua Nei Ke Za Zhi; 1997 Sep; 36(9):595-8. PubMed ID: 10436968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of G-->T mutation at codon 12 of H-ras oncogenes in gastric cancers with polymerase chain reaction and oligodeoxynucleotide(PCR-ODN)].
    Liu XF
    Zhonghua Bing Li Xue Za Zhi; 1992 Dec; 21(6):364-7. PubMed ID: 1299531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases.
    Yamada Y; Yoshida T; Hayashi K; Sekiya T; Yokota J; Hirohashi S; Nakatani K; Nakano H; Sugimura T; Terada M
    Cancer Res; 1991 Nov; 51(21):5800-5. PubMed ID: 1933850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difference of p53AIP1 mRNA expression in gastric mucosa between patients with gastric cancer and chronic gastritis infected with Helicobacter pylori.
    Sawaya M; Yoshimura T; Shimoyama T; Munakata A; Fukuda S
    J Clin Gastroenterol; 2008 Apr; 42(4):351-5. PubMed ID: 18277906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDX-2 homeobox gene expression in human gastric carcinoma and precursor lesions.
    Kim HS; Lee JS; Freund JN; Min KW; Lee JS; Kim W; Juhng SW; Park CS
    J Gastroenterol Hepatol; 2006 Feb; 21(2):438-42. PubMed ID: 16509871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are lymphocytic monoclonality and immunoglobulin heavy chain (IgH) rearrangement premalignant conditions in chronic gastritis?
    Wündisch T; Thiede C; Alpen B; Stolte M; Neubauer A
    Microsc Res Tech; 2001 Jun; 53(6):414-8. PubMed ID: 11525259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point mutation at codon 12 of the c-Ha-ras gene in human gastric cancers.
    Koh EH; Chung HC; Lee KB; Han EK; Oh SH; Min JS; Choi EM; Youn JK; Kim BS
    J Korean Med Sci; 1992 Jun; 7(2):110-5. PubMed ID: 1524724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype.
    Albino AP; Nanus DM; Mentle IR; Cordon-Cardo C; McNutt NS; Bressler J; Andreeff M
    Oncogene; 1989 Nov; 4(11):1363-74. PubMed ID: 2682463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 alteration in gastric precancerous lesions.
    Shiao YH; Rugge M; Correa P; Lehmann HP; Scheer WD
    Am J Pathol; 1994 Mar; 144(3):511-7. PubMed ID: 8129036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multiple analysis for the c-Ha-ras activation and DNA content in human gastric precancerous lesions].
    Yu J; Zhang J
    Zhonghua Nei Ke Za Zhi; 1995 Nov; 34(11):739-42. PubMed ID: 8731843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic and genotypic events in gastric carcinogenesis.
    Correa P; Shiao YH
    Cancer Res; 1994 Apr; 54(7 Suppl):1941s-1943s. PubMed ID: 8137316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity on 10q23.3 and mutation of tumor suppressor gene PTEN in gastric cancer and precancerous lesions.
    Li YL; Tian Z; Wu DY; Fu BY; Xin Y
    World J Gastroenterol; 2005 Jan; 11(2):285-8. PubMed ID: 15633233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.